|
1
|
Muniraj T, Jamidar PA and Aslanian HR:
Pancreatic cancer: A comprehensive review and update. Dis Mon.
59:368–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keane MG, Bramis K, Pereira SP and Fusai
GK: Systematic review of novel ablative methods in locally advanced
pancreatic cancer. World J Gastroenterol. 20:2267–2278. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan YL, Zheng M, Tang YL and Liang XH: A
new perspective of vasculogenic mimicry: EMT and cancer stem cells
(Review). Oncol Lett. 6:1174–1180. 2013.PubMed/NCBI
|
|
4
|
Lima J Felipe, Nofech-Mozes S, Bayani J
and Bartlett JM: EMT in breast carcinoma-A review. J Clin Med.
5(pii): E652016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rogers CD, Saxena A and Bronner ME: Sip1
mediates an E-cadherin-to-N-cadherin switch during cranial neural
crest EMT. J Cell Biol. 203:835–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Badea TC, Niculescu FI, Soane L, Shin ML
and Rus H: Molecular cloning and characterization of RGC-32, a
novel gene induced by complement activation in oligodendrocytes. J
Biol Chem. 273:26977–26981. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Badea T, Niculescu F, Soane L, Fosbrink M,
Sorana H, Rus V, Shin ML and Rus H: RGC-32 increases p34CDC2 kinase
activity and entry of aortic smooth muscle cells into S-phase. J
Biol Chem. 277:502–508. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fosbrink M, Cudrici C, Niculescu F, Badea
TC, David S, Shamsuddin A, Shin ML and Rus H: Overexpression of
RGC-32 in colon cancer and other tumors. Exp Mol Pathol.
78:116–122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vogelmann R, Nguyen-Tat MD, Giehl K, Adler
G, Wedlich D and Menke A: TGFbeta-induced downregulation of
E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN.
J Cell Sci. 118:4901–4912. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang WY, Li ZG, Rus H, Wang X, Jose PA
and Chen SY: RGC-32 mediates transforming growth
factor-beta-induced epithelial-mesenchymal transition in human
renal proximal tubular cells. J Biol Chem. 284:9426–9432. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu L, Qin H, Li PY, Xu SN, Pang HF, Zhao
HZ, Li DM and Zhao Q: Response gene to complement-32 enhances
metastatic phenotype by mediating transforming growth factor
beta-induced epithelial-mesenchymal transition in human pancreatic
cancer cell line BxPC-3. J Exp Clin Cancer Res. 31:292012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen X, Xue Y, Si Y, Wang Q, Wang Z, Yuan
J and Zhang X: The unfolded protein response potentiates
epithelial-to-mesenchymal transition (EMT) of gastric cancer cells
under severe hypoxic conditions. Med Oncol. 32:4472015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ackerman D and Simon MC: Hypoxia, lipids,
and cancer: Surviving the harsh tumor microenvironment. Trends Cell
Biol. 24:472–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choudhry H, Albukhari A, Morotti M, Haider
S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et
al: Tumor hypoxia induces nuclear paraspeckle formation through
HIF-2α dependent transcriptional activation of NEAT1 leading to
cancer cell survival. Oncogene. 34:45462015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang J, Tang YL and Liang XH: EMT: A new
vision of hypoxia promoting cancer progression. Cancer Biol Ther.
11:714–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zepeda AB, Pessoa A Jr, Castillo RL,
Figueroa CA, Pulgar VM and Farias JG: Cellular and molecular
mechanisms in the hypoxic tissue: Role of HIF-1 and ROS. Cell
Biochem Funct. 31:451–459. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang YJ, Na HJ, Suh MJ, Ban MJ, Byeon HK,
Kim WS, Kim JW, Choi EC, Kwon HJ, Chang JW and Koh YW: Hypoxia
induces epithelial-mesenchymal transition in follicular thyroid
cancer: Involvement of regulation of twist by hypoxia inducible
factor-1α. Yonsei Med J. 56:1503–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weidemann A and Johnson RS: Biology of
HIF-1alpha. Cell Death Differ. 15:621–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang F, Yin J, Lu Z, Zhang G, Li J, Xing
T, Zhuang S and Wang N: Limb ischemic preconditioning protects
against contrast-induced nephropathy via renalase. EBioMedicine.
9:356–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang F, Zhang G, Xing T, Lu Z, Li J, Peng
C, Liu G and Wang N: Renalase contributes to the renal protection
of delayed ischaemic preconditioning via the regulation of
hypoxia-inducible factor-1α. J Cell Mol Med. 19:1400–1409. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian Q, Xue Y, Zheng W, Sun R, Ji W, Wang
X and An R: Overexpression of hypoxia-inducible factor 1α induces
migration and invasion through Notch signaling. Int J Oncol.
47:728–738. 2015.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Semenza GL: Oxygen sensing,
hypoxia-inducible factors, and disease pathophysiology. Annu Rev
Pathol. 9:47–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao T, Li JZ, Lu Y, Zhang CY, Li Q, Mao J
and Li LH: The mechanism between epithelial mesenchymal transition
in breast cancer and hypoxia microenvironment. Biomed Pharmacother.
80:393–405. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. 138:1058–1066.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cammarata PR, Neelam S and Brooks MM:
Inhibition of hypoxia inducible factor-1α downregulates the
expression of epithelial to mesenchymal transition early marker
proteins without undermining cell survival in hypoxic lens
epithelial cells. Mol Vis. 21:1024–1035. 2015.PubMed/NCBI
|
|
28
|
Morishita Y, Ookawara S, Hirahara I, Muto
S and Nagata D: HIF-1α mediates Hypoxia-induced
epithelial-mesenchymal transition in peritoneal mesothelial cells.
Ren Fail. 38:282–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heldin CH, Landström M and Moustakas A:
Mechanism of TGF-beta signaling to growth arrest, apoptosis, and
epithelial-mesenchymal transition. Curr Opin Cell Biol. 21:166–176.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
An X, Jin Y, Guo H, Foo SY, Cully BL, Wu
J, Zeng H, Rosenzweig A and Li J: Response gene to complement 32, a
novel hypoxia-regulated angiogenic inhibitor. Circulation.
120:617–627. 2009. View Article : Google Scholar : PubMed/NCBI
|
